AI-Powered Continuous Health Monitoring for Chronic Disease Management in Malaysia: Real-Time Risk Prediction Using Wearable Sensors and Digital Biomarkers

Main Article Content

Umi Najiah Ahmad Razimi
Yong Yoke Leng
Nor Hapiza Mohd Ariffin
Mohammed Hazim Alkawaz

Abstract

Chronic Non-Communicable Diseases (NCDs), such as diabetes mellitus, hypertension, and cardiovascular disease, make up a significant portion of the mortality cases in Malaysia, as well as impose consistent demands for costs related to health care expenditure. According to the cost reports at the national level, major NCDs (cardiovascular disease, diabetes, and cancer) are responsible for RM 9.65 billion annually as direct healthcare cost [3]. However, the current approach to managing chronic diseases focuses heavily on periodic assessments in clinic setting at weekly or monthly intervals. Here, a predictive analysis framework based on AI technology, leveraging continuous monitoring with patient data collected from consumer wearables to predict potential health events up to five days ahead is proposed. A synthetic dataset was generated to simulate the behaviour of 500 patients affected by diabetes and/or hypertension, who were continuously monitored throughout a year for heart rate, heart rate variability, physical activity, sleep indices, and blood pressure features. The models are compared to determine the optimal algorithm in the case study. The LSTM model showed 93.7% accuracy in predicting five days in advance, outperforming the random forest model (91.5%), XGBoost model (90.6%), and the simple threshold rule-based approach (78.6%). The sensitivity and specificity scores of the LSTM model were 87.6% and 95.9%, respectively, while the ROC-AUC score was 0.983. According to the SHAP analysis, previous heart rate values (history for three days and seven days) have the largest contributions in predicting patient outcomes, followed by changes in heart rate variability and low activity levels. Although evaluation is based on synthetic data for methodological validation, the framework is intended for extension to real-world wearable streams to support earlier risk detection and more proactive chronic disease management.

Article Details

How to Cite
Ahmad Razimi, U. N., Leng, Y. Y., Mohd Ariffin, N. H., & Alkawaz, M. H. (2026). AI-Powered Continuous Health Monitoring for Chronic Disease Management in Malaysia: Real-Time Risk Prediction Using Wearable Sensors and Digital Biomarkers. Journal of Informatics and Web Engineering, 5(2), 361–382. https://doi.org/10.33093/jiwe.2026.5.2.22
Section
(Thematic) AI in Health and Wellness

References

Ministry of Health Malaysia, Salt Reduction Strategy to Prevent and Control Non-Communicable Diseases for Malaysia 2021–2025. Putrajaya, Malaysia: Ministry of Health Malaysia, 2021. [Online]. Available: https://www.moh.gov.my/moh/resources/Penerbitan/Rujukan/NCD/Garam/Salt_Reduction_Strategy_To_Prevent_And_Control_NCD_For_Malaysia_2021-2025_26082021.pdf. Accessed: 23 Jan. 2026

World Health Organization and Ministry of Health Malaysia, Prevention and Control of Noncommunicable Diseases in Malaysia: The Case for Investment. 2024. [Online]. Available: https://www.who.int/malaysia/internal-publications-detail/prevention-and-control-of-noncommunicable-diseases-in-malaysia. Accessed: 23 Jan. 2026.

Ministry of Health Malaysia, The Direct Health-care Cost of Noncommunicable Diseases in Malaysia. Putrajaya, Malaysia: Ministry of Health Malaysia, 2022. [Online]. Available: https://www.moh.gov.my/moh/resources/Penerbitan/Rujukan/NCD/NCD_Laporan/HEALTH-COST_of_NCDs-7a-WEB.pdf. Accessed: 23 Jan. 2026.

World Health Organization, Regional Office for the Western Pacific, “Transforming health: Malaysia’s RM 30 billion NCD strategy,” 16 Dec. 2024. [Online]. Available: https://www.who.int/westernpacific/newsroom/feature-stories/item/transforming-health–malaysia-s-rm-30-billion-ncd-strategy. Accessed: 23 Jan. 2026.

Department of Statistics Malaysia, “Peluncuran MyAgeing Dashboard (Press Statement),” 06 Sep. 2024. [Online]. Available: https://www.dosm.gov.my/uploads/content-downloads/file_20240906121413.pdf. Accessed: 23 Jan. 2026.

S. Akhtar, A. Nasir, M. Abbas, and M. Asghar, “Prevalence of type-2 diabetes and prediabetes in Malaysia: A systematic review and meta-analysis,” PLOS ONE, vol. 17, no. 2, pp. e0263139, 2022, doi: 10.1371/journal.pone.0263139.

Ministry of Health Malaysia, Academy of Medicine Malaysia, Malaysia Endocrine & Metabolic Society, Family Medicine Specialists Association of Malaysia, and Diabetes Malaysia, Clinical Practice Guidelines: Management of Type 2 Diabetes Mellitus, 6th ed. Putrajaya, Malaysia, Dec. 2020. [Online]. Available: https://mems.my/wp-content/uploads/2021/03/CPG-T2DM_6th-Edition-2020_210226.pdf. Accessed: 23 Jan. 2026.

H. Thirumurthy et al., “Differences between self-reported and electronically monitored adherence among patients receiving antiretroviral therapy in a resource-limited setting,” AIDS, vol. 26, no. 18, pp. 2399–2403, Nov. 2012, doi: 10.1097/QAD.0b013e328359aa68.

M. J. Stirratt et al., “Self-report measures of medication adherence behavior: Recommendations on optimal use,” Translational Behavioral Medicine, vol. 5, no. 4, pp. 470–482, Dec. 2015, doi: 10.1007/s13142-015-0315-2.

H. Ismail et al., “Mapping the Locations of Medical Specialists in the Ministry of Health’s Hospitals in Malaysia by Specialty, Subspecialty and Area of Interest,” Malaysian Journal of Medical Sciences, vol. 31, no. 3, pp. 1–17, Jun. 2024, doi: 10.21315/mjms2024.31.3.1.

B. A. Ahmad, K. Khairatul, and A. Farnaza, “An assessment of patient waiting and consultation time in a primary healthcare clinic,” Malaysian Family Physician, vol. 12, no. 1, pp. 14–21, 2017.

S. N. Abd Wahab, N. H. Mohd Satar, and M. Tumin, “Urban poor: Evidence of barriers in accessing public clinics in Kuala Lumpur, Malaysia,” Malaysian Journal of Public Health Medicine, vol. 22, no. 1, pp. 193–204, 2022, doi: 10.37268/mjphm/vol.22/no.1/art.1148.

J. Ab Hamid, M. H. Juni, R. Abdul Manaf, S. N. Syed Ismail, and P. Y. Lim, “Spatial accessibility of primary care in the dual public–private health system in rural areas, Malaysia,” International Journal of Environmental Research and Public Health, vol. 20, no. 4, Art. no. 3147, 2023, doi: 10.3390/ijerph20043147.

International Data Corporation (IDC), “IDC forecasts continued growth for wearables but growth will be uneven across product categories,” 26 Sep. 2024. [Online]. Available: https://my.idc.com/getdoc.jsp?containerId=prUS52615024. Accessed: 23 Jan. 2026.

S. A. A. Seman, “A structural investigation on behavioural intention among young adult users toward smartwatch adoption in Malaysia,” Malaysian Journal of Consumer and Family Economics, vol. 28, pp. 467–482, 2022.

K. B. Kim, and H. J. Baek, “Photoplethysmography in wearable devices: A comprehensive review of technological advances, current challenges, and future directions,” Electronics, vol. 12, no. 13, Art. no. 2923, 2023, doi: 10.3390/electronics12132923.

D. R. Bassett Jr, L. P. Toth, S. R. LaMunion, and S. E. Crouter, “Step counting: A review of measurement considerations and health-related applications,” Sports Medicine, vol. 47, no. 7, pp. 1303–1315, Jul. 2017, doi: 10.1007/s40279-016-0663-1.

A. E. Schutte, “Wearable cuffless blood pressure tracking: when will they be good enough?” Journal of Human Hypertension, vol. 38, no. 9, pp. 669–672, 2024, doi: 10.1038/s41371-024-00932-3.

D. L. Cohen, and J. R. Townsend, “How significant is white coat hypertension?” Current Hypertension Reports, vol. 12, pp. 165–167, 2010, doi: 10.1007/s11906-010-0115-2.

M. V. Perez et al., “Large-scale assessment of a smartwatch to identify atrial fibrillation,” The New England Journal of Medicine, vol. 381, no. 20, pp. 1909–1917, 2019, doi: 10.1056/NEJMoa1901183.

G. Quer et al., “Wearable sensor data and self-reported symptoms for COVID-19 detection,” Nature Medicine, vol. 27, no. 1, pp. 73–77, 2021, doi: 10.1038/s41591-020-1123-x.

S. Hochreiter, and J. Schmidhuber, “Long short-term memory,” Neural Computation, vol. 9, no. 8, pp. 1735–1780, 1997, doi: 10.1162/neco.1997.9.8.1735.

W. P. T. M. van Doorn et al., “Machine learning-based glucose prediction with use of continuous glucose and physical activity monitoring data: The Maastricht Study,” PLOS ONE, vol. 16, no. 6, pp. e0253125, 2021, doi: 10.1371/journal.pone.0253125.

S. Nemati, M. M. Holder, F. Razmi, M. D. Stanley, G. D. Clifford, and T. J. Buchman, “An interpretable machine learning model for accurate prediction of sepsis in the ICU,” Critical Care Medicine, vol. 46, no. 4, pp. 547–553, 2018, doi: 10.1097/CCM.0000000000002936.

A. Y. Hannun et al., “Cardiologist-level arrhythmia detection and classification in ambulatory electrocardiograms using a deep neural network,” Nature Medicine, vol. 25, no. 1, pp. 65–69, 2019, doi: 10.1038/s41591-018-0268-3.

S. M. Lundberg, and S.-I. Lee, “A unified approach to interpreting model predictions,” in Advances in Neural Information Processing Systems, vol. 30. Red Hook, NY, USA: Curran Associates, 2017.

N. I. Mohamed Nazar, N. S. Ab Rahman, N. E. Alias, S. Zaini, T. K. Tg Mohd Kamil, N. A. Jamani, and M. H. Elnaem, “Impak Sihat: A telehealth system development and feasibility evaluation to empower rural population in Malaysia on the quality use of medicines,” PLOS Digit. Health, vol. 4, no. 8, pp. e0000937, Aug. 2025, doi: 10.1371/journal.pdig.0000937.

D. A. Abdullah, M. A. Wazdi, H. M. Azri, and A. M. Ishak, “Satisfaction with virtual consultation services in Selangor, Malaysia: A cross-sectional study,” Cureus, vol. 16, no. 6, pp. e63347, Jun. 2024, doi: 10.7759/cureus.63347.

Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology, “Heart rate variability: Standards of measurement, physiological interpretation and clinical use,” European Heart Journal, vol. 17, no. 3, pp. 354–381, 1996.

H. Tsuji, M. G. Larson, F. J. Venditti, Jr., E. S. Manders, J. C. Evans, C. L. Feldman, and D. Levy, “Impact of reduced heart rate variability on risk for cardiac events: The Framingham Heart Study,” Circulation, vol. 94, no. 11, pp. 2850–2855, 1996, doi: 10.1161/01.CIR.94.11.2850.

A. I. Vinik, M. Erbas, and T. S. Casellini, “Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease,” Journal of Diabetes Investigation, vol. 4, no. 1, pp. 4–18, 2013, doi: 10.1111/jdi.12042.

K. Fox et al. , “Resting heart rate in cardiovascular disease,” Journal of the American College of Cardiology, vol. 50, no. 9, pp. 823–830, 2007, doi: 10.1016/j.jacc.2007.04.079.

B. del Pozo Cruz, J. del Pozo Cruz, M. A. Ahmadi, F. B. Ortega, I.-M. Lee, and E. Stamatakis, “Association of daily step count and intensity with all-cause mortality in US adults,” JAMA Internal Medicine, vol. 182, no. 7, pp. 776–784, 2022, doi: 10.1001/jamainternmed.2022.2321.

A. Pandey et al., “Continuous dose-response association between sedentary time and risk for cardiovascular disease: A meta-analysis,” JAMA Cardiology, vol. 1, no. 5, pp. 575–583, 2016, doi: 10.1001/jamacardio.2016.1567.

A. J. Cooper, F. N. Cappuccio, P. D’Elia, P. Strazzullo, and M. A. Miller, “Sleep duration predicts cardiovascular outcomes: A systematic review and meta-analysis of prospective studies,” European Heart Journal, vol. 32, no. 12, pp. 1484–1492, 2011, doi: 10.1093/eurheartj/ehr007.

B. Lechat, N. A. Naik, K. A. Reynolds, A. A. A. H. H. Sethi, and D. J. Eckert, “New and emerging approaches to better define sleep and circadian physiology and diagnostics,” Frontiers in Neuroscience, vol. 15, Art. no. 751730, 2021, doi: 10.3389/fnins.2021.751730.

K. Kario et al. , "Prognostic significance of home blood pressure monitoring in the general population," Journal of the American College of Cardiology., vol. 73, no. 4, pp. 402–414, Feb. 2019, doi: 10.1016/j.jacc.2018.10.076.

P. M. Rothwell et al., "Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension," The Lancet, vol. 375, no. 9718, pp. 895–905, Mar. 2010, doi: 10.1016/S0140-6736(10)60308-X.

J. Daniels, P. Herrero, and P. Georgiou, “A multitask learning approach to personalized blood glucose prediction,” IEEE Journal of Biomedical and Health Informatics, vol. 26, no. 1, pp. 436–445, Jan. 2022, doi: 10.1109/JBHI.2021.3100558.

A. van Wyk, A. Khojandi, and A. Kamaleswaran, “A hierarchical analysis of real-time data: A sepsis case study,” IEEE Journal of Biomedical and Health Informatics, vol. 23, no. 3, pp. 978–986, 2019, doi: 10.1109/JBHI.2018.2874706.

L. Breiman, “Random forests,” Machine Learning, vol. 45, no. 1, pp. 5–32, 2001, doi: 10.1023/A:1010933404324.

J. H. Friedman, “Greedy function approximation: A gradient boosting machine,” The Annals of Statistics, vol. 29, no. 5, pp. 1189–1232, 2001, doi: 10.1214/aos/1013203451.

P. Kasl et al. , “Utilizing wearable device data for syndromic surveillance: A fever detection approach,” Sensors (Basel), vol. 24, no. 6, Art. no. 1818, 2024, doi: 10.3390/s24061818.

A. Duran, and K. Jongsma, “Who is afraid of black box algorithms? On the epistemological and ethical basis of trust in medical AI,” Journal of Medical Ethics, 2021, doi: 10.1136/medethics-2020-106820.

S. M. Lundberg et al., “From local explanations to global understanding with explainable AI for trees,” Nature Machine Intelligence, vol. 2, no. 1, pp. 56–67, 2020, doi: 10.1038/s42256-019-0138-9.

D. B. Raja et al., “Artificial intelligence model as predictor for dengue outbreaks,” Malaysian Journal of Public Health Medicine, vol. 19, no. 2, pp. 103–108, 2019, doi: 10.37268/mjphm/vol.19/no.2/art.176.

N. A. Mohd Salim et al, “Prediction of dengue outbreak in Selangor, Malaysia using machine learning techniques,” Scientific Reports, vol. 11, Art. no. 939, 2021, doi: 10.1038/s41598-020-79193-2.

O. Baker, Z. Ziran, M. Mecella, and K. Subaramaniam, “AI-driven melanoma detection in New Zealand: A ResNet50-based approach,” Informatics in Medicine Unlocked, vol. 58, Art. no. 101697, 2025, doi: 10.1016/j.imu.2025.101697.

O. Baker, Z. Ziran, M. Mecella, K. Subaramaniam, and S. Palaniappan, “Predictive modelling for pandemic forecasting: A COVID-19 study in New Zealand and partner countries,” International Journal of Environmental Research and Public Health, vol. 22, no. 4, Art. no. 562, 2025, doi: 10.3390/ijerph22040562.

O. Baker, K. Subaramaniam, A. S. Shibghatullah, Z. A. Shaffiei, and A. S. S. Amir Hamzah, “A collaborative framework for disease prediction using machine learning,” in Proceeding 2025 IEEE International Conference on Artificial Intelligence in Engineering and Technology (IICAIET), Kota Kinabalu, Malaysia, 2025, pp. 650–654, doi: 10.1109/IICAIET67254.2025.11265309.

Department of Statistics Malaysia, Key Findings of Population and Housing Census of Malaysia 2020: Urban and Rural (STATS ALERT #259), Putrajaya, Malaysia, Dec. 23, 2022. [Online]. Available: https://www.dosm.gov.my/portal-main/release-document-log?cat=stats_alert&release_document_id=18519&type=pdf. Accessed: 23 Jan. 2026.

C. Tudor-Locke, and D. R. Bassett, “How many steps/day are enough? Preliminary pedometer indices for public health,” Sports Medicine, vol. 34, no. 1, pp. 1–8, 2004, doi: 10.2165/00007256-200434010-00001.

M. A. Majeed, H. Z. M. Shafri, Z. Zulkafli, and A. Wayayok, “A deep learning approach for dengue fever prediction in Malaysia using LSTM with spatial attention,” International Journal of Environmental Research and Public Health, vol. 20, no. 5, Art. no. 4130, 2023.

A. Ahmed, S. Aziz, A. Abd alrazaq, F. Farooq, M. Househ, and J. Sheikh, “The effectiveness of wearable devices using artificial intelligence for blood glucose level forecasting or prediction: Systematic review,” Journal of Medical Internet Research, vol. 25, Art. no. e40259, 2023.

B. Singh et. al. , “Real-world accuracy of wearable activity trackers for detecting medical conditions: Systematic review and meta-analysis,” JMIR mHealth and uHealth, vol. 12, Art. no. e56972, 2024.

M. Alshami, R. Abdulghafor, and A. Aborujilah, “Extending the unified theory of acceptance and use of technology for COVID-19 contact tracing application by Malaysian users,” Sustainability, vol. 14, no. 11, Art. no. 6811, 2022.